Fried was previously co-founder and CEO of Explorer Surgical, which sold to GHX in 2021. She resigned from the company in June 2022, leaving us to wonder what was next for the venture capital investor.
One year later, she’s an investor and the chief executive at Flow Medical. The Chicago-based startup is developing a new catheter system for treating pulmonary embolism (PE). PE is caused by blood clots that break off from deep vein thrombosis (DVT) and head to the lungs. Of the estimated 900,000 PE cases in the U.S. each year, around 100,000 are fatal.
The other two co-founders of Flow Medical are Chief Scientif…